Trials have shown that there is huge potential of psychedelics in treating psychiatric disorders, including smoking addiction, with a success rate of up to 67% at one year after the quit date, compared to nicotine replacement's success rate of 10-25% and the best medication (Vareniclin) at only 35% after six months.